The study included data from people with a recent history of obesity and excluded those with diabetes or who have been prescribed another Scientists analyzed the data to see how many people developed one of four gastrointestinal conditions pancreatitis, bowel obstruction, gastroparesis, and Researchers found that the participants who took GLP-1 agonists had a little over nine times higher risk of developing pancreatitis, 4.22 times higher risk of having a bowel obstruction, and 3.67 times increased risk for gastroparesis, compared to people who took We are not entirely surprised [by these results]
A: Results vary, but many see significant progress within the first few months, especially with lifestyle changes
With proper nutrition and resistance training, muscle building can continue
This is why bacteriostatic water contains benzyl alcohol
Korkushko OV, et al
Although oral formulations such as semaglutide have improved accessibility, there is ongoing demand for longer-acting agents with less frequent dosing schedules